|
시장보고서
상품코드
1915337
암 지지요법 시장(2025-2029년)Global Cancer Supportive Care Market 2025-2029 |
||||||
세계의 암 지지요법 시장은 2024-2029년 CAGR 4.4%로 67억 2,350만 달러 증가할 것으로 예측됩니다. 본 보고서에서는 세계의 암 지지요법 시장에 관한 종합적 분석, 시장 규모와 예측, 동향, 성장요인, 과제와 약 25개사 벤더 분석 등의 정보를 제공합니다.
본 보고서는 현재 시장 상황, 최신 동향 및 성장요인, 시장 환경 전반에 대한 최신 분석을 제공합니다. 암 환자 증가, 암 치료에 따른 많은 부작용, 개발도상국의 미개척 잠재력에 의해 시장이 주도되고 있습니다.
본 조사는 업계 주요 관계자들의 정보를 포함한 1차 정보와 2차 정보를 객관적으로 조합하여 실시되었습니다. 이 보고서에는 주요 기업 분석과 함께 종합적인 시장 규모 데이터, 지역별 분석과 함께 부문 및 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 포함되어 있습니다.
| 시장 범위 | |
|---|---|
| 기준 연도 | 2025년 |
| 종료 연도 | 2029년 |
| 예측 기간 | 2025-2029년 |
| 성장 모멘텀 | 가속 |
| 전년대비 | 4.1% |
| CAGR | 4.4% |
| 증가액 | 67억 2,350만 달러 |
이 보고서는 암 관련 치료에서 바이오시밀러의 등장이 향후 몇 년 동안 세계 암 보조요법 시장의 성장을 주도할 주요 요인 중 하나로 꼽았습니다. 또한, 바이오시밀러 제조 활동의 외주화 및 다양한 전략의 도입으로 시장에서 상당한 수요가 발생할 것으로 예측됩니다.
목차
제1장 주요 요약
제2장 Technavio 분석
- 가격, 수명주기, 고객 구입 바스켓, 채택 비율, 구입 기준 분석
- 인풋의 중요성과 차별화 요인
- 혼란 요인
- 성장 촉진요인과 과제의 영향
제3장 시장 구도
- 시장 생태계
- 시장 특징
- 밸류체인 분석
제4장 시장 규모
- 시장의 정의
- 시장 부문 분석
- 시장 규모(2024년)
- 시장 전망(2024-2029년)
제5장 시장 규모 실적
- 세계의 암 지지요법 시장(2019-2023년)
- 치료 영역별 분석(2019-2023년)
- 유통 채널별 분석(2019-2023년)
- 용도별 분석(2019-2023년)
- 지역별 분석(2019-2023년)
- 국가별 분석(2019-2023년)
제6장 정성 분석
- AI의 영향 : 세계의 암 지지요법 시장
제7장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁 위협
- 시장 현황
제8장 시장 세분화 : 치유 영역별
- 비교 : 치유 영역별
- 화학요법에 따른 빈혈
- 화학요법에 따른 호중구 감소증
- 암성 통증
- 화학요법 유발 오심 및 구토(CINV)
- 기타
- 시장 기회 : 치유 영역별
제9장 시장 세분화 : 유통 채널별
- 비교 : 유통 채널별
- 병원 약국
- 드럭스토어 및 소매 약국
- 온라인 공급업체
- 시장 기회 : 유통 채널별
제10장 시장 세분화 : 용도별
- 비교 : 용도별
- 유방암
- 대장암
- 위암
- 간암
- 전립선암
- 시장 기회 : 용도별
제11장 고객 상황
제12장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 네덜란드
- 스페인
- 아시아
- 중국
- 일본
- 인도
- 한국
- 인도네시아
- 세계 기타 지역
- 브라질
- 사우디아라비아
- 아르헨티나
- 호주
- 아랍에미리트(UAE)
- 콜롬비아
- 남아프리카공화국
- 이스라엘
- 튀르키예
- 시장 기회 : 지역별
제13장 촉진요인·과제·기회
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회
제14장 경쟁 구도
- 개요
- 경쟁 구도
- 파괴적 혁신 상황
- 업계 리스크
제15장 경쟁 분석
- 기업 개요
- 기업 순위 지표
- 기업의 시장 포지셔닝
- Amgen Inc.
- Baxter International Inc.
- Bayer AG
- Daiichi Sankyo Co. Ltd.
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- Helsinn Healthcare SA
- Heron Therapeutics Inc.
- Johnson and Johnson Services
- Kyowa Kirin Co. Ltd.
- Merck and Co. Inc.
- Novartis AG
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Ltd.
제16장 부록
LSH 26.02.04The global cancer supportive care market is forecasted to grow by USD 6723.5 mn during 2024-2029, accelerating at a CAGR of 4.4% during the forecast period. The report on the global cancer supportive care market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of cancer cases, many side effects associated with cancer treatment, untapped potential in developing countries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 4.1% |
| CAGR | 4.4% |
| Incremental Value | $6723.5 mn |
Technavio's global cancer supportive care market is segmented as below:
By Therapeutic Area
- Chemotherapy-induced anemia
- Chemotherapy-induced neutropenia
- Cancer pain
- CINV
- Others
By Distribution Channel
- Hospitals pharmacies
- Drug stores and retail pharmacies
- Online providers
By Application
- Breast cancer
- Colorectal cancer
- Stomach cancer
- Liver cancer
- Prostate cancer
Geography
- North America
- US
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- The Netherlands
- Spain
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the advent of biosimilars in cancer-associated treatment as one of the prime reasons driving the global cancer supportive care market growth during the next few years. Also, outsourcing of biosimilars manufacturing activities and adoption of various strategies will lead to sizable demand in the market.
The report on the global cancer supportive care market covers the following areas:
- Global cancer supportive care market sizing
- Global cancer supportive care market forecast
- Global cancer supportive care market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global cancer supportive care market vendors that include Amgen Inc., APR Applied Pharma Research SA, Baxter International Inc., Bayer AG, Daiichi Sankyo Co. Ltd., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Helsinn Healthcare SA, Heron Therapeutics Inc., Johnson and Johnson Services, Kyowa Kirin Co. Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Ltd.. Also, the global cancer supportive care market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Therapeutic Area
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
5 Historic Market Size
- 5.1 Global Cancer Supportive Care Market 2019 - 2023
- Historic Market Size - Data Table on Global Cancer Supportive Care Market 2019 - 2023 ($ million)
- 5.2 Therapeutic Area segment analysis 2019 - 2023
- Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
- 5.3 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
- 5.4 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 The AI impact on Global Cancer Supportive Care Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
8 Market Segmentation by Therapeutic Area
- 8.1 Market segments
- 8.2 Comparison by Therapeutic Area
- 8.3 Chemotherapy-induced anemia - Market size and forecast 2024-2029
- 8.4 Chemotherapy-induced neutropenia - Market size and forecast 2024-2029
- 8.5 Cancer pain - Market size and forecast 2024-2029
- 8.6 CINV - Market size and forecast 2024-2029
- 8.7 Others - Market size and forecast 2024-2029
- 8.8 Market opportunity by Therapeutic Area
- Market opportunity by Therapeutic Area ($ million)
9 Market Segmentation by Distribution Channel
- 9.1 Market segments
- 9.2 Comparison by Distribution Channel
- 9.3 Hospitals pharmacies - Market size and forecast 2024-2029
- 9.4 Drug stores and retail pharmacies - Market size and forecast 2024-2029
- 9.5 Online providers - Market size and forecast 2024-2029
- 9.6 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Application
- 10.1 Market segments
- 10.2 Comparison by Application
- 10.3 Breast cancer - Market size and forecast 2024-2029
- 10.4 Colorectal cancer - Market size and forecast 2024-2029
- 10.5 Stomach cancer - Market size and forecast 2024-2029
- 10.6 Liver cancer - Market size and forecast 2024-2029
- 10.7 Prostate cancer - Market size and forecast 2024-2029
- 10.8 Market opportunity by Application
- Market opportunity by Application ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2024-2029
- 12.3.1 US - Market size and forecast 2024-2029
- 12.3.2 Canada - Market size and forecast 2024-2029
- 12.3.3 Mexico - Market size and forecast 2024-2029
- 12.4 Europe - Market size and forecast 2024-2029
- 12.4.1 UK - Market size and forecast 2024-2029
- 12.4.2 Germany - Market size and forecast 2024-2029
- 12.4.3 France - Market size and forecast 2024-2029
- 12.4.4 Italy - Market size and forecast 2024-2029
- 12.4.5 The Netherlands - Market size and forecast 2024-2029
- 12.4.6 Spain - Market size and forecast 2024-2029
- 12.5 Asia - Market size and forecast 2024-2029
- 12.5.1 China - Market size and forecast 2024-2029
- 12.5.2 Japan - Market size and forecast 2024-2029
- 12.5.3 India - Market size and forecast 2024-2029
- 12.5.4 South Korea - Market size and forecast 2024-2029
- 12.5.5 Indonesia - Market size and forecast 2024-2029
- 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- 12.6.1 Brazil - Market size and forecast 2024-2029
- 12.6.2 Saudi Arabia - Market size and forecast 2024-2029
- 12.6.3 Argentina - Market size and forecast 2024-2029
- 12.6.4 Australia - Market size and forecast 2024-2029
- 12.6.5 UAE - Market size and forecast 2024-2029
- 12.6.6 Colombia - Market size and forecast 2024-2029
- 12.6.7 South Africa - Market size and forecast 2024-2029
- 12.6.8 Israel - Market size and forecast 2024-2029
- 12.6.9 Turkey - Market size and forecast 2024-2029
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Growing prevalence of cancer cases
- Many side effects associated with cancer treatment
- Untapped potential in developing countries
- 13.2 Market challenges
- High cost of cancer treatment
- Rising popularity of targeted therapies in developed countries
- Inadequate reimbursement policies
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 13.4 Market opportunities
- Advent of biosimilars in cancer-associated treatment
- Outsourcing of biosimilars manufacturing activities
- Adoption of various strategies
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
- 15.5 Baxter International Inc.
- Baxter International Inc. - Overview
- Baxter International Inc. - Business segments
- Baxter International Inc. - Key news
- Baxter International Inc. - Key offerings
- Baxter International Inc. - Segment focus
- SWOT
- 15.6 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
- 15.7 Daiichi Sankyo Co. Ltd.
- Daiichi Sankyo Co. Ltd. - Overview
- Daiichi Sankyo Co. Ltd. - Business segments
- Daiichi Sankyo Co. Ltd. - Key offerings
- Daiichi Sankyo Co. Ltd. - Segment focus
- SWOT
- 15.8 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 15.9 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- 15.10 Helsinn Healthcare SA
- Helsinn Healthcare SA - Overview
- Helsinn Healthcare SA - Product / Service
- Helsinn Healthcare SA - Key offerings
- SWOT
- 15.11 Heron Therapeutics Inc.
- Heron Therapeutics Inc. - Overview
- Heron Therapeutics Inc. - Business segments
- Heron Therapeutics Inc. - Key offerings
- Heron Therapeutics Inc. - Segment focus
- SWOT
- 15.12 Johnson and Johnson Services
- Johnson and Johnson Services - Overview
- Johnson and Johnson Services - Business segments
- Johnson and Johnson Services - Key news
- Johnson and Johnson Services - Key offerings
- Johnson and Johnson Services - Segment focus
- SWOT
- 15.13 Kyowa Kirin Co. Ltd.
- Kyowa Kirin Co. Ltd. - Overview
- Kyowa Kirin Co. Ltd. - Business segments
- Kyowa Kirin Co. Ltd. - Key offerings
- Kyowa Kirin Co. Ltd. - Segment focus
- SWOT
- 15.14 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
- 15.15 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- 15.16 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
- 15.17 Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings
- SWOT
- 15.18 Teva Pharmaceutical Ltd.
- Teva Pharmaceutical Ltd. - Overview
- Teva Pharmaceutical Ltd. - Business segments
- Teva Pharmaceutical Ltd. - Key news
- Teva Pharmaceutical Ltd. - Key offerings
- Teva Pharmaceutical Ltd. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
